DTL
BPMC

Dynamic Technology Lab’s Blueprint Medicines BPMC Stock Holding History

Dynamic Technology Lab’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,436
Closed -$212K – 1021
2024
Q4 		$212K Buy
+2,436
New +$223K 0.03% 747
2023
Q1 		– Sell
-8,820
Closed -$386K – 1110
2022
Q4 		$386K Buy
8,820
+5,470
+163% +$262K 0.04% 684
2022
Q3 		$221K Sell
3,350
-3,300
-50% -$212K 0.02% 924
2022
Q2 		$336K Buy
+6,650
New +$390K 0.04% 724
2021
Q1 		– Sell
-4,218
Closed -$473K – 1158
2020
Q4 		$473K Buy
+4,218
New +$445K 0.08% 475

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dynamic Technology Lab's BPMC Position: Q1 2025 in Review

Dynamic Technology Lab sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 2,436 shares — an estimated $212K sold.

Dynamic Technology Lab first reported a position in BPMC in Q4 2020 and held it in 5 quarters. The position peaked at $473K in Q4 2020. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.

  • Dynamic Technology Lab reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 2,436 Blueprint Medicines shares in Q1 2025, an estimated $212K.
  • Dynamic Technology Lab first reported a position in Blueprint Medicines in Q4 2020 and held it in 5 quarters.
  • Dynamic Technology Lab's Blueprint Medicines position peaked at $473K in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.

Based on Dynamic Technology Lab's 13F filing for Q1 2025, filed 16 May 2025.